These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 34043202)

  • 1. Assessment of Cytotoxicity of α-Synuclein in Budding Yeast Using a Spot Growth Assay and Fluorescent Microscopy.
    Takaine M
    Methods Mol Biol; 2021; 2322():163-174. PubMed ID: 34043202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Posttranslational Modifications and Clearing of α-Synuclein Aggregates in Yeast.
    Popova B; Kleinknecht A; Braus GH
    Biomolecules; 2015 Apr; 5(2):617-34. PubMed ID: 25915624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. alpha-Synuclein, oxidative stress and apoptosis from the perspective of a yeast model of Parkinson's disease.
    Witt SN; Flower TR
    FEMS Yeast Res; 2006 Dec; 6(8):1107-16. PubMed ID: 17156009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Yeast-Based Screens to Target Alpha-Synuclein Toxicity.
    Brás IC; Popova B; Braus GH; Outeiro TF
    Methods Mol Biol; 2019; 1948():145-156. PubMed ID: 30771176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the Toxic Metals Arsenite and Cadmium on α-Synuclein Aggregation In Vitro and in Cells.
    Lorentzon E; Horvath I; Kumar R; Rodrigues JI; Tamás MJ; Wittung-Stafshede P
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Yeast red pigment modifies cloned human α-synuclein pathogenesis in Parkinson disease models in Saccharomyces cerevisiae and Drosophila melanogaster.
    Nevzglyadova OV; Mikhailova EV; Artemov AV; Ozerova YE; Ivanova PA; Golomidov IM; Bolshakova OI; Zenin VV; Kostyleva EI; Soidla TR; Sarantseva SV
    Neurochem Int; 2018 Nov; 120():172-181. PubMed ID: 30099122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The benefits of humanized yeast models to study Parkinson's disease.
    Franssens V; Bynens T; Van den Brande J; Vandermeeren K; Verduyckt M; Winderickx J
    Oxid Med Cell Longev; 2013; 2013():760629. PubMed ID: 23936613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From Yeast to Humans: Leveraging New Approaches in Yeast to Accelerate Discovery of Therapeutic Targets for Synucleinopathies.
    Piotrowski JS; Tardiff DF
    Methods Mol Biol; 2019; 2049():419-444. PubMed ID: 31602625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Yeast unfolds the road map toward alpha-synuclein-induced cell death.
    Franssens V; Boelen E; Anandhakumar J; Vanhelmont T; Büttner S; Winderickx J
    Cell Death Differ; 2010 May; 17(5):746-53. PubMed ID: 20019751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylation, lipid raft interaction and traffic of alpha-synuclein in a yeast model for Parkinson.
    Zabrocki P; Bastiaens I; Delay C; Bammens T; Ghillebert R; Pellens K; De Virgilio C; Van Leuven F; Winderickx J
    Biochim Biophys Acta; 2008 Oct; 1783(10):1767-80. PubMed ID: 18634833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidative stress in Alzheimer's and Parkinson's diseases: insights from the yeast Saccharomyces cerevisiae.
    Pimentel C; Batista-Nascimento L; Rodrigues-Pousada C; Menezes RA
    Oxid Med Cell Longev; 2012; 2012():132146. PubMed ID: 22701754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Robust Sequence Determinants of α-Synuclein Toxicity in Yeast Implicate Membrane Binding.
    Newberry RW; Arhar T; Costello J; Hartoularos GC; Maxwell AM; Naing ZZC; Pittman M; Reddy NR; Schwarz DMC; Wassarman DR; Wu TS; Barrero D; Caggiano C; Catching A; Cavazos TB; Estes LS; Faust B; Fink EA; Goldman MA; Gomez YK; Gordon MG; Gunsalus LM; Hoppe N; Jaime-Garza M; Johnson MC; Jones MG; Kung AF; Lopez KE; Lumpe J; Martyn C; McCarthy EE; Miller-Vedam LE; Navarro EJ; Palar A; Pellegrino J; Saylor W; Stephens CA; Strickland J; Torosyan H; Wankowicz SA; Wong DR; Wong G; Redding S; Chow ED; DeGrado WF; Kampmann M
    ACS Chem Biol; 2020 Aug; 15(8):2137-2153. PubMed ID: 32786289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aggresome formation and segregation of inclusions influence toxicity of α-synuclein and synphilin-1 in yeast.
    Swinnen E; Büttner S; Outeiro TF; Galas MC; Madeo F; Winderickx J; Franssens V
    Biochem Soc Trans; 2011 Oct; 39(5):1476-81. PubMed ID: 21936837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nicotine slows down oligomerisation of α-synuclein and ameliorates cytotoxicity in a yeast model of Parkinson's disease.
    Kardani J; Sethi R; Roy I
    Biochim Biophys Acta Mol Basis Dis; 2017 Jun; 1863(6):1454-1463. PubMed ID: 28167231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-Terminal Tyrosine Residue Modifications Modulate the Protective Phosphorylation of Serine 129 of α-Synuclein in a Yeast Model of Parkinson's Disease.
    Kleinknecht A; Popova B; Lázaro DF; Pinho R; Valerius O; Outeiro TF; Braus GH
    PLoS Genet; 2016 Jun; 12(6):e1006098. PubMed ID: 27341336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolating potentiated Hsp104 variants using yeast proteinopathy models.
    Jackrel ME; Tariq A; Yee K; Weitzman R; Shorter J
    J Vis Exp; 2014 Nov; (93):e52089. PubMed ID: 25407485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-terminal deletion does not affect α-synuclein membrane binding, self-association and toxicity in human neuroblastoma cells, unlike yeast.
    Vamvaca K; Lansbury PT; Stefanis L
    J Neurochem; 2011 Oct; 119(2):389-97. PubMed ID: 21848810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative Characterization of α-Synuclein Aggregation in Living Cells through Automated Microfluidics Feedback Control.
    Perrino G; Wilson C; Santorelli M; di Bernardo D
    Cell Rep; 2019 Apr; 27(3):916-927.e5. PubMed ID: 30995486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of formation of α-synuclein inclusions by mannosylglycerate in a yeast model of Parkinson's disease.
    Faria C; Jorge CD; Borges N; Tenreiro S; Outeiro TF; Santos H
    Biochim Biophys Acta; 2013 Aug; 1830(8):4065-72. PubMed ID: 23608058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A peroxisome biogenesis deficiency prevents the binding of alpha-synuclein to lipid droplets in lipid-loaded yeast.
    Wang S; Horn PJ; Liou LC; Muggeridge MI; Zhang Z; Chapman KD; Witt SN
    Biochem Biophys Res Commun; 2013 Aug; 438(2):452-6. PubMed ID: 23916615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.